SCOPUS 정보 검색 플랫폼

Annals of Internal Medicine

Volumn 134, Issue 6, 2001, Pages 475-477

HIV resistance testing in clinical practice: A QALY-fied success

(1) Saag, M S a

a UNIVERSITY OF ALABAMA AT BIRMINGHAM (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EDITORIAL; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TREATMENT FAILURE; VIRUS LOAD; VIRUS RESISTANCE;

EID: 0035916925 PISSN: 00034819 EISSN: None Source Type: Journal
DOI: 10.7326/0003-4819-134-6-200103200-00012 Document Type: Editorial

Times cited : (10)

References (16)

1
- 0003296135
- Meta-analysis of efficacy of triple combination therapy in antiretroviral naïve HIV infected adults
- San Francisco, California, 30 January-2 February 2000. Alexandria, VA: Foundation for Retrovirology and Human Health. Abstract no. 519
- (2000) Seventh Conference on Retroviruses and Opportunistic Infections
- Bartlett, J.A.¹ DeMasi, R.² Quinn, J.³ Moxham, C.⁴ Rousseau, F.⁵

2
- 0007010412
- Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel
- PMID: 0009660368
- (1998) JAMA , vol.280 , pp. 78-86
- Carpenter, C.C.¹ Fischl, M.A.² Hammer, S.M.³ Hirsch, M.S.⁴ Jacobsen, D.M.⁵ Katzenstein, D.A.⁶

3
- 0035253297
- Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history alone in patients with human immunodeficiency virus infection
- PMID: 0011133371
- (2001) J Infect Dis , vol.183 , pp. 401-408
- Call, S.A.¹ Saag, M.S.² Westfall, A.O.³ Raper, J.L.⁴ Pham, S.V.⁵ Tolson, J.M.⁶

4
- 0343183245
- Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
- PMID: 0010815085
- (2000) JAMA , vol.283 , pp. 2417-2426
- Hirsch, M.S.¹ Brun-Vezinet, F.² D'Aquila, R.T.³ Hammer, S.M.⁴ Johnson, V.A.⁵ Kuritzkes, D.R.⁶

5
- 0034685037
- Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
- PMID: 0010647802
- (2000) JAMA , vol.283 , pp. 381-390
- Carpenter, C.C.¹ Cooper, D.A.² Fischl, M.A.³ Gatell, J.M.⁴ Gazzard, B.G.⁵ Hammer, S.M.⁶

6
- 0003667696
- Department of Health and Human Services and the Henry J. Kaiser Family Foundation, 28 January
- (2000) Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

7
- 0034630829
- HIV genotype and phenotype - Arresting resistance?
- PMID: 0010815093
- (2000) JAMA , vol.283 , pp. 2442-2444
- Flexner, C.¹

8
- 0035916915
- Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness
- (2001) Ann Intern Med , vol.134 , pp. 440-450
- Weinstein, M.C.¹ Goldie, S.J.² Losina, E.³ Cohen, C.J.⁴ Baxter, J.D.⁵ Zhang, H.⁶

9
- 0029794708
- Recommendations of the panel on cost-effectiveness in health and medicine
- PMID: 0008849754
- (1996) JAMA , vol.276 , pp. 1253-1258
- Weinstein, M.C.¹ Siegel, J.E.² Gold, M.R.³ Kamlet, M.S.⁴ Russell, L.B.⁵

10
- 0032515391
- The cost-effectiveness of preventing AIDS-related opportunistic infections
- PMID: 0009440663
- (1998) JAMA , vol.279 , pp. 130-136
- Freedberg, K.A.¹ Scharfstein, J.A.² Seage III, G.R.³ Losina, E.⁴ Weinstein, M.C.⁵ Craven, D.E.⁶

11
- 0033920318
- A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
- CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. [PMID: 0010894268]
- (2000) AIDS , vol.14
- Baxter, J.D.¹ Mayers, D.L.² Wentworth, D.N.³ Neaton, J.D.⁴ Hoover, M.L.⁵ Winters, M.A.⁶

12
- 0033606540
- Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
- PMID: 0010392984
- (1999) Lancet , vol.353 , pp. 2195-2199
- Durant, J.¹ Clevenbergh, P.² Halfon, P.³ Delgiudice, P.⁴ Porsin, S.⁵ Simonet, P.⁶

13
- 0004152165
- Springfield, VA: National Technical Information Service
- (1995) Multicenter AIDS Cohort Study (MACS) Public Dataset: Release PO4

14
- 0033541468
- Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: Application to a clinical trial
- PMID: 0010221527
- (1999) AIDS Res Hum Retroviruses , vol.15 , pp. 499-508
- Cook, J.¹ Dasbach, E.² Coplan, P.³ Markson, L.⁴ Yin, D.⁵ Meibohm, A.⁶

15
- 0029785605
- Combination antiretroviral therapy in HIV infection. An economic perspective
- PMID: 0010163413
- (1996) Pharmacoeconomics , vol.10 , pp. 109-113
- Moore, R.D.¹ Bartlett, J.G.²

16
- 0005867302
- The clinical utility of HIV genotyping: The Havanna Trial
- Toronto, Canada, September 2000. Washington, DC: American Soc for Microbiology. Abstract no. L-10
- (2000) 40th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Tural, C.¹ Ruiz, L.² Holtzer, C.³ Viciana, P.⁴ Gonzalez, J.⁵ Ferrer, E.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.